A tailored course, built for your situation
Compliance-Ready AI in Pharmaceutical R&D Operations for Multi-Site Programs
A 12-module implementation-grade course for business and technology leaders advancing AI governance in global drug development
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Deploying AI in multi-site pharmaceutical R&D without a compliance-first framework risks delays, audit findings, and rework.
The situation this course is for
Teams are under pressure to deliver AI-driven insights faster while meeting strict regulatory standards across jurisdictions. Without structured guidance, even well-intentioned initiatives can fall short during inspections or fail to scale across sites.
Who this is for
Business and technology professionals in pharmaceuticals and life sciences managing AI deployment across global R&D programs with compliance, governance, or operational oversight responsibilities.
Who this is not for
Individuals seeking introductory AI overviews or non-regulated industry applications.
What you walk away with
- Design AI systems that meet current FDA and EMA expectations for transparency and traceability
- Implement audit-ready documentation practices across distributed research teams
- Align AI model validation with ICH guidelines and GxP principles
- Coordinate cross-site data governance with centralized compliance oversight
- Reduce time-to-approval cycles through proactive regulatory alignment
The 12 modules (with all 144 chapters)
Module 1. Foundations of AI Compliance in Regulated R&D
Introduces core compliance principles, regulatory landscape, and AI-specific risk categories in pharmaceutical development.
12 chapters in this module
- Defining compliance-ready AI
- Regulatory bodies and expectations overview
- Key AI risks in drug development
- Jurisdictional variation in oversight
- GxP and AI interaction points
- Data integrity in AI workflows
- Model lifecycle governance
- Stakeholder alignment strategies
- Compliance by design framework
- Risk-based validation approaches
- Audit preparedness fundamentals
- Case study: early-phase trial support
Module 2. Data Governance Across Multi-Site Trials
Covers data standardization, access controls, and metadata management for AI use across global sites.
12 chapters in this module
- Multi-site data harmonization
- CDISC compliance for AI inputs
- Data provenance tracking
- Role-based access in clinical settings
- Cross-border data flow considerations
- Data quality assurance frameworks
- Version control for datasets
- Metadata standards for interpretability
- Data lineage documentation
- Handling missing or inconsistent data
- Audit trail design for AI systems
- Case study: Phase III trial integration
Module 3. Model Validation and Documentation Standards
Details how to validate AI models according to regulatory expectations and maintain compliant records.
12 chapters in this module
- Validation vs verification distinctions
- Prospective validation planning
- Retrospective model assessment
- Documentation for regulatory review
- Model performance benchmarks
- Bias detection and mitigation
- Sensitivity analysis techniques
- Version tracking for models
- Change control workflows
- Revalidation triggers
- Audit package assembly
- Case study: dose-response prediction model
Module 4. Operationalizing AI in GCP-Regulated Environments
Explores integration of AI tools into clinical trial operations under Good Clinical Practice.
12 chapters in this module
- GCP principles and AI
- Trial protocol integration
- Adverse event prediction systems
- Site monitoring augmentation
- Centralized oversight models
- Data safety monitoring boards
- AI-assisted query resolution
- Patient recruitment optimization
- Consent process support tools
- Endpoint adjudication workflows
- Performance monitoring in real time
- Case study: decentralized trial analytics
Module 5. AI in GLP-Regulated Preclinical Studies
Covers application of AI in non-clinical labs with adherence to Good Laboratory Practice.
12 chapters in this module
- GLP framework overview
- Toxicity prediction models
- Histopathology image analysis
- Automated reporting workflows
- Raw data preservation rules
- Electronic lab notebook integration
- Model explainability for pathologists
- Validation under OECD principles
- Cross-platform reproducibility
- Audit readiness in preclinical labs
- Staff training on AI outputs
- Case study: in silico toxicology screening
Module 6. GMP-Compliant AI for Manufacturing Support
Focuses on AI use in pharmaceutical production with alignment to Good Manufacturing Practice.
12 chapters in this module
- Process analytical technology (PAT)
- Real-time release testing
- Batch failure prediction
- Deviation root cause analysis
- AI in quality control labs
- Change control integration
- Model validation for production
- Alarm management systems
- Data integrity in manufacturing
- Audit trail compliance
- Staff qualification requirements
- Case study: predictive maintenance in bioreactors
Module 7. Cross-Site Coordination and Change Management
Addresses leadership, training, and process alignment across international teams.
12 chapters in this module
- Centralized vs decentralized governance
- Change management frameworks
- Training program development
- Language and cultural considerations
- Time zone coordination strategies
- Knowledge transfer protocols
- Escalation pathways
- Vendor management integration
- Performance metric alignment
- Remote audit readiness
- Crisis response planning
- Case study: global Phase II rollout
Module 8. Regulatory Submission Readiness
Prepares teams to include AI components in regulatory filings with confidence.
12 chapters in this module
- AI in IND/CTA submissions
- Model description requirements
- Validation evidence packaging
- FDA AI/ML guidance alignment
- EMA reflection paper compliance
- Transparency documentation
- Software as a medical device considerations
- Algorithm performance summaries
- Version control in submissions
- Post-market update planning
- Inter-agency harmonization
- Case study: submission for AI-augmented biomarker discovery
Module 9. Ethical AI and Patient Safety Oversight
Ensures AI deployment upholds ethical standards and protects participant safety.
12 chapters in this module
- Ethical review board engagement
- Bias in patient selection models
- Informed consent for AI use
- Privacy preserving techniques
- Explainability for clinicians
- Human-in-the-loop design
- Incident reporting systems
- Patient data rights compliance
- Equity in trial access algorithms
- Safety monitoring thresholds
- Fallback procedures
- Case study: AI in rare disease recruitment
Module 10. Scalable AI Infrastructure for Global Programs
Covers technical architecture that supports compliance across regions and studies.
12 chapters in this module
- Cloud infrastructure compliance
- Containerization and reproducibility
- Version-controlled pipelines
- Data residency strategies
- Encryption in transit and at rest
- Disaster recovery planning
- High availability requirements
- Monitoring and logging
- DevOps in regulated environments
- Infrastructure as code validation
- Cost optimization with compliance
- Case study: multi-region trial data platform
Module 11. Continuous Monitoring and Model Lifecycle Management
Establishes processes for ongoing AI performance and compliance oversight.
12 chapters in this module
- Performance drift detection
- Automated alerting systems
- Periodic review cycles
- Retraining workflows
- Feedback loops from sites
- Model retirement procedures
- Stakeholder reporting templates
- Regulatory change impact assessment
- Incident response coordination
- Model version sunset planning
- Archival requirements
- Case study: real-world evidence model refresh
Module 12. Future-Proofing AI Strategy in Pharma R&D
Aligns current practices with emerging regulatory and technological trends.
12 chapters in this module
- Anticipating regulatory evolution
- AI in adaptive trial designs
- Digital twin applications
- Federated learning compliance
- Synthetic data use cases
- Blockchain for audit trails
- Interoperability standards
- Patient-generated data integration
- AI in personalized medicine
- Sustainability in AI operations
- Talent development roadmap
- Case study: next-gen R&D platform design
How this maps to your situation
- Designing AI systems for regulatory inspection
- Managing model validation across global sites
- Integrating AI into clinical trial workflows
- Preparing AI components for regulatory submission
Before vs. after
Before
Uncertainty about how to deploy AI in a way that meets evolving regulatory expectations across jurisdictions.
After
Confidence to lead compliant, scalable AI initiatives in multi-site pharmaceutical R&D programs.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 60, 70 hours total, self-paced, with implementation-focused exercises and templates designed for real-world application.
If nothing changes
Continuing without a structured approach to compliance-ready AI may result in delayed approvals, audit findings, or rework during inspections, slowing innovation and increasing costs.
How this compares to the alternatives
Unlike generic AI ethics courses or high-level overviews, this program delivers implementation-grade content specific to pharmaceutical R&D, with actionable templates and regulatory alignment strategies not available in public resources or vendor training.
Frequently asked
Who is this course designed for?
It’s for business and technology professionals leading or supporting AI initiatives in multi-site pharmaceutical R&D with responsibility for compliance, governance, or operational delivery.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this relevant for non-US regulatory environments?
Yes, the course addresses compliance expectations from the FDA, EMA, PMDA, and other major agencies with global applicability.
$199 one-time. Approximately 60, 70 hours total, self-paced, with implementation-focused exercises and templates designed for real-world application..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours